Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
Few healthcare companies are more famous than Johnson Johnson (NYSE: JNJ). The pharmaceutical giant earned its stature in the industry thanks to its incredible innovative abilities and a business that's been executing for decades.
However, its growth has stalled in recent years. The company's financial results haven't been particularly strong, and it's also dealing with a barrage of lawsuits and other legal challenges.
Though Johnson Johnson remains one of the largest healthcare companies in the world by market cap, several others could overtake it within the next decade. Here are two prime candidates: Vertex Pharmaceuticals (NASDAQ: VRTX) and Intuitive Surgical (NASDAQ: ISRG).
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
426,00 €
-0,12 %
Die Vertex Pharmaceuticals Inc. Aktie zieht viel Aufmerksamkeit auf sich: Viel mehr Buy- als Sell-Einschätzungen.
Ein Kursziel von 440 € für Vertex Pharmaceuticals Inc. zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 426.0 €.
